Ancora Advisors’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Ancora Advisors’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,006	Closed	-$56	–	1877
2023 Q3	$56	Hold	1,006	–	–	﹤0.01%	1748
2023 Q2	$129	Hold	1,006	–	–	﹤0.01%	1738
2023 Q1	$80	Hold	1,006	–	–	﹤0.01%	1906
2022 Q4	$0	Hold	1,006	–	–	﹤0.01%	2154
2022 Q3	$0	Hold	1,006	–	–	﹤0.01%	2316
2022 Q2	$0	Buy	+1,006	New	+$188	﹤0.01%	2473

Ancora Advisors's BIOSW Position: Q4 2023 in Review

Ancora Advisors sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 1,006 shares — an estimated $56 sold.

Ancora Advisors first reported a position in BIOSW in Q2 2022 and held it in 6 quarters. The position peaked at $129 in Q2 2023. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Ancora Advisors reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Ancora Advisors sold 1,006 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $56.
Ancora Advisors first reported a position in BioPlus Acquisition Corp. Warrants in Q2 2022 and held it in 6 quarters.
Ancora Advisors's BioPlus Acquisition Corp. Warrants position peaked at $129 in Q2 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Ancora Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.